Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline

Cited by (1,000)

Items 701–800 of 1,000

1. Neuropathology of Alzheimer's Disease and its Variants
   Charles J. Duyckaerts, Dennis W. Dickson · 2011 · Wiley eBooks
2. MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer’s Disease
   Ivana Raffaele, Serena Silvestro, Emanuela Mazzon · 2023 · International Journal of Molecular Sciences
3. Disease-modifying therapies for Alzheimer’s disease: Clinical trial progress and opportunity
   Yujie Zhang, Jie Chen, Yanru Li, Bin Jiao, Shilin Luo · 2024 · Ageing Research Reviews
4. Neuronal tetraploidization in the cerebral cortex correlates with reduced cognition in mice and precedes and recapitulates Alzheimer's-associated neuropathology
   Noelia López‐Sánchez, Ángela Fontán‐Lozano, Anna Pallé, Valentina González-Álvarez, Alberto Rábano, José Luís Trejo, José María Frade · 2017 · Neurobiology of Aging
5. Amyloid Imaging in Alzheimer’s Disease and Other Dementias
   Michelle T. Fodero‐Tavoletti, Roberto Cappai, Catriona McLean, Kerryn Elizabeth Pike, Paul Anthony Adlard, Tiffany Cowie, Andrea R. Connor, Colin Louis Masters, Christopher Cleon Rowe, Victor L. Villemagne · 2009 · Brain Imaging and Behavior
6. Studies of the effects of fragment (25?35) of beta-amyloid peptide on the behavior of rats in a radial maze
   M. Yu. Stepanichev, Yu. V. Moiseeva, Н. А. Лазарева, Natalia V. Gulyaeva · 2005 · Neuroscience and Behavioral Physiology
7. Amyloid cascade hypothesis
   Deng-Shun Wang, Dennis W. Dickson, James S. Malter · 2011 · Figshare
8. Elevated soluble amyloid beta protofibrils in Down syndrome and Alzheimer's disease
   Malin Johannesson, Charlotte Sahlin, Linda Söderberg, Hans Basun, Johanna M. Fälting, Christer Möller, Olof Zachrisson, Dan Sunnemark, Anne Svensson, Tomas Odergren et al. · 2021 · Molecular and Cellular Neuroscience
9. Changes in cholesterol metabolism-related gene expression in peripheral blood mononuclear cells from Alzheimer patients
   Antonella Mandas, Claudia Abete, Paolo Francesco Putzu, Paolo La Colla, Sandra Dessı̀, Alessandra Pani · 2012 · Lipids in Health and Disease
10. Alzheimer?s disease?a sum greater than its parts?
    Paul Anthony Adlard, Brian J Cummings · 2004 · Neurobiology of Aging
11. Postmortale Diagnosestellung bei Morbus Alzheimer
    Dietmar Rudolf Thal, H. Braak · 2004 · Der Pathologe
12. Protein Aggregation in Alzheimers Disease and Other Neoropathological Disorders
    Aristotelis C. Dimakopoulos · 2005 · Current Alzheimer Research
13. Does IFNγ play a role in neurodegeneration?
    Imrich Blasko, Gerhard N. Ransmayr, Robert Veerhuis, Piet Eikelenboom, Beatrix Grubeck‐Loebenstein · 2001 · Journal of Neuroimmunology
14. Preclinical and clinical challenges in the development of disease-modifying therapies for Alzheimer's disease
    Carol A. Scorer · 2001 · Drug Discovery Today
15. Molecular imaging of dementia
    Takaaki Mori, Jun Maeda, Hitoshi Shimada, Makoto Higuchi, Hitoshi Shinotoh, Shuichi Ueno, Tetsuya Suhara · 2012 · Psychogeriatrics
16. Brain mGluR5 in mice with amyloid beta pathology studied with in vivo [11C]ABP688 PET imaging and ex vivo immunoblotting
    Xiaotian T. Fang, Jonas Eriksson, Gunnar Antoni, Ulrika Yngve, Linda Cato, Lars Lannfelt, Dag Sehlin, Stina Syvänen · 2016 · Neuropharmacology
17. Hippocampal Proteomic Analysis Reveals Distinct Pathway Deregulation Profiles at Early and Late Stages in a Rat Model of Alzheimer’s-Like Amyloid Pathology
    Sonia Do Carmo, Gogce C. Crynen, Tiffany Paradis, Jon M. Reed, M. Florencia Iulita, Adriana Ducatenzeiler, Fiona Crawford, A. Claudio Cuello · 2017 · Molecular Neurobiology
18. Pathogenic Feed-Forward Mechanisms in Alzheimer’s and Parkinson’s Disease Converge on GSK-3
    Abdalla M. Albeely, Scott D. Ryan, Melissa L. Perreault · 2018 · Brain Plasticity
19. Comparison between amyloid-PET and CSF amyloid-β biomarkers in a clinical cohort with memory deficits
    Caroline Bouter, Jonathan S. Vogelgsang, Jens Wiltfang · 2019 · Clinica Chimica Acta
20. Intracellular Localization of Amyloid-β Peptide in SH-SY5Y Neuroblastoma Cells
    Lin Ping Zheng, Javier Calvo‐Garrido, Martin Hallbeck, Kjell R. Hultenby, Jan O. Marcusson, Ángel Cedazo-Mı́nguez, Alexei Terman · 2013 · Journal of Alzheimer s Disease
21. Amyloid Beta-Protein and Neural Network Dysfunction
    Fernando Peña‐Ortega · 2013 · Journal of Neurodegenerative Diseases
22. Cortical pyroglutamate amyloid-β levels and cognitive decline in Alzheimer's disease
    Violetta N. Pivtoraiko, Eric E. Abrahamson, Sue E. Leurgans, Steven Trent DeKosky, Elliott Jay Mufson, Miloš D. Ikonomović · 2014 · Neurobiology of Aging
23. Reactions of One-Electron-Oxidized Methionine with Oxygen: An ab Initio Study
    Mei Lan Huang, Arvi Rauk · 2004 · The Journal of Physical Chemistry A
24. What Can Rodent Models Tell Us About Cognitive Decline in Alzheimer's Disease?
    Sabrina Davis, Serge Laroche · 2003 · Molecular Neurobiology
25. Peptides from sesame cake reduce oxidative stress and amyloid-β-induced toxicity by upregulation of SKN-1 in a transgenic Caenorhabditis elegans model of Alzheimer’s disease
    Xiaoli Ma, Xiaodong Cui, Jiao Li, Chen Li, Zhuanhua Wang · 2017 · Journal of Functional Foods
26. Vinpocetine mitigates aluminum-induced cognitive impairment in socially isolated rats
    Azza A. Ali, Hebatalla I. Ahmed, Sahar A. Khaleel, Karema Abu‐Elfotuh · 2019 · Physiology & Behavior
27. Toward an Early Diagnosis and Treatment of Alzheimer’s Disease
    Agneta K. Nordberg · 2003 · International Psychogeriatrics
28. Altered filamin A enables amyloid beta-induced tau hyperphosphorylation and neuroinflammation in Alzheimer’s disease
    Lindsay H. Burns, Hoau-Yan Wang · 2017 · Neuroimmunology and Neuroinflammation
29. Growth factor treatment to overcome Alzheimer's dysfunctional signaling
    Marc-Antoine Lauzon, Alex Daviau, Bernard Marcos, Nathalie Faucheux · 2015 · Cellular Signalling
30. Ex Situ Atomic Force Microscopy Analysis of β-Amyloid Self-Assembly and Deposition on a Synthetic Template
    Chanki Ha, Chan Beum Park · 2006 · Langmuir
31. p38 Mitogen Activated Protein Kinase as a Therapeutic Target for Alzheimer's Disease
    Stacie A. Dalrymple · 2002 · Journal of Molecular Neuroscience
32. Proteolytic generation and aggregation of peptides from transmembrane regions: lung surfactant protein C and amyloid ?-peptide
    Jan Johansson, Timothy E. Weaver, Lars O. Tjernberg · 2004 · Cellular and Molecular Life Sciences
33. Estrogen Replacement Therapy for the Potential Treatment or Prevention of Alzheimer's Disease
    Marilyn M. Miller, Andrew A. Monjan, Neil S. Buckholtz · 2001 · Annals of the New York Academy of Sciences
34. Entorhinal cortex vulnerability to human APP expression promotes hyperexcitability and tau pathology
    Goettemoeller, Annie M., Banks, Emmie, Kumar, Prateek, Olah, Viktor J., McCann, Katharine E., South, Kelly, Ramelow, Christina C., Eaton, Anna, Duong, Duc M., Seyfried, Nicholas T. et al. · 2024 · Nature Communications
35. The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment
    Zieneldien, Tarek, Kim, Janice, Cao, Chuanhai · 2022 · Geriatrics
36. Targeting Generation of Antibodies Specific to Conformational Epitopes of Amyloid β-Derived Neurotoxins
    Lambert, Mary, Velasco, Pauline, Viola, Kirsten, Klein, William · 2009 · CNS & Neurological Disorders - Drug Targets
37. Natural Products as Novel Neuroprotective Agents; Computational Predictions of the Molecular Targets, ADME Properties, and Safety Profile
    Sahar S. Alghamdi, Rasha Saad Suliman, Norah Abdulaziz Aljammaz, Khawla Mohammed Kahtani, Dimah Aljatli, Ghadeer Mohsen Albadrani · 2022 · Plants
38. Reversal of Aggregation Using β-Breaker Dipeptide Containing Peptides: Application to Aβ(1–40) Self-Assembly and Its Inhibition
    Krishna Chaitanya Nadimpally, Ashim Paul, Bhubaneswar Mandal · 2014 · ACS Chemical Neuroscience
39. Cognitive Decline and Modulation of Alzheimer’s Disease-Related Genes After Inhibition of MicroRNA-101 in Mouse Hippocampal Neurons
    Christian Barbato, Giacomo Giacovazzo, F. Albiero, Raffaella Scardigli, Chiara Scopa, M. T. Ciotti, Georgios Strimpakos, Roberto Coccurello, Francesca Ruberti · 2020 · Molecular Neurobiology
40. Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer’s Disease
    Mauro Fà, Hong Zhang, Agnieszka Staniszewski, Faisal Saeed, Li W. Shen, Isaac T. Schiefer, Marton I. Siklos, Subhasish Tapadar, Vladislav A. Litosh, Jenny M. Libien et al. · 2015 · Journal of Alzheimer s Disease
41. Amyloid Beta Peptide Slows Down Sensory-Induced Hippocampal Oscillations
    Fernando Peña‐Ortega, Ramón Bernal‐Pedraza · 2012 · International Journal of Peptides
42. Concomitant detection of β-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice
    Wolfgang Härtig, Simone Goldhammer, Ute U.I. Bauer, Florian Wegner, Oliver Wirths, Thomas A. Bayer, Jens Grosche · 2010 · Journal of Chemical Neuroanatomy
43. Amyloid β peptide promotes differentiation of pro-inflammatory human myeloid dendritic cells
    Antonio Ciaramella, Nunzia Sanarico, Federica Bizzoni, Maria Luisa Moro, Francesca Salani, Giuseppe Scapigliati, Gianfranco Spalletta, Carlo Caltagirone, Paola Bossù · 2007 · Neurobiology of Aging
44. Exercise Prevents Amyloid-β-Induced Hippocampal Network Disruption by Inhibiting GSK3β Activation
    Arturo G. Isla, Francisco Gabriel Vázquez‐Cuevas, Fernando Peña‐Ortega · 2016 · Journal of Alzheimer s Disease
45. Consideration of the ischaemic basis and treatment of Alzheimer's disease.
    Ryszard M. Pluta, Marzena Ułamek, Mirosław Jabłoński · 2010 · PubMed
46. Development of the clinical candidate PBD-C06, a humanized pGlu3-Aβ-specific antibody against Alzheimer’s disease with reduced complement activation
    Thore Hettmann, Stephen D. Gillies, Martin Kleinschmidt, Anke Piechotta, Koki Makioka, Cynthia Ann Lemere, Stephan Schilling, Jens‐Ulrich Rahfeld, Inge Lues · 2020 · Scientific Reports
47. Dynamic Changes in the Levels of Amyloid-β42 Species in the Brain and Periphery of APP/PS1 Mice and Their Significance for Alzheimer’s Disease
    Liding Zhang, Changwen Yang, Yanqing Li, Shiqi Niu, Xiaohan Liang, Zhihong Zhang, Qingming Luo, Haiming Luo · 2021 · Frontiers in Molecular Neuroscience
48. Transition metal chelator therapy - a potential treatment for Alzheimer's disease?
    Anastazija Gnjec · 2002 · Frontiers in bioscience
49. Amyloid PET Ligands for Dementia
    Victor L. Villemagne, Christopher Cleon Rowe · 2010 · PET Clinics
50. Association of CSF apolipoprotein E, Aβ42 and cognition in Alzheimer’s disease
    Markus J. Riemenschneider, M. Schmolke, Nicola T. Lautenschlager, Hugo Vanderstichele, Eugeen Vanmechelen, W. G. Guder, Alexander Kurz · 2002 · Neurobiology of Aging
51. Sonic hedgehog signalling pathway contributes in age-related disorders and Alzheimer’s disease
    Parashar, Arun, jha, Dhruv, Mehta, Vineet, Chauhan, Bonney, Ghosh, Pappu, Deb, Prashanta Kumar, Jaiswal, Mohit, Prajapati, Santosh Kumar · 2024 · Ageing Research Reviews
52. Striatum and entorhinal cortex atrophy in AD mouse models: MRI comprehensive analysis
    Edoardo Micotti, Alessandra Paladini, Claudia Balducci, Daniele Tolomeo, Angelisa Frasca, Moira Marizzoni, Marta Filibian, Anna Caroli, Giovanni Valbusa, Sophie L. Dix et al. · 2014 · Neurobiology of Aging
53. Synthesis and Evaluation of Fluorine-18 Labeled 2-Phenylquinoxaline Derivatives as Potential Tau Imaging Agents
    Kaixiang Zhou, Fan Yang, Yuying Li, Yimin Chen, Xiaojun Zhang, Jinming Zhang, Junfeng Wang, Jiapei Dai, Lisheng Cai, Mengchao Cui · 2021 · Molecular Pharmaceutics
54. Of mice and men: more neurobiology in dementia
    Alina Codita, Bengt G. Winblad, Abdul Hafeez Mohammed · 2006 · Current Opinion in Psychiatry
55. Caspase-3 cleaved spectrin colocalizes with neurofilament-immunoreactive neurons in Alzheimer’s disease
    Carlos A. Ayala‐Grosso, James P. Tam, Sophie Roy, Steven Xanthoudakis, D. Da Costa, Donald W. Nicholson, George S. Robertson · 2006 · Neuroscience
56. Coassembly of Peptides Derived from β-Sheet Regions of β-Amyloid
    Nicholas L. Truex, James S. Nowick · 2016 · Journal of the American Chemical Society
57. Anesthesia, the aging brain, and the surgical patient
    Gregory J. Crosby, Deborah J. Culley · 2003 · Canadian Journal of Anesthesia/Journal canadien d anesthésie
58. Elevated mRNA-Levels of Gonadotropin-Releasing Hormone and Its Receptor in Plaque-Bearing Alzheimer's Disease Transgenic Mice
    Syed Nuruddin, Gry H. E. Syverstad Skaaraas, Sveinung Lillehaug, Trygve Brauns Leergaard, Lars N. G. Nilsson, Erik Ropstad, Anette Krogenæs, Ira Haraldsen, Reidun Torp · 2014 · PLoS ONE
59. Hippocampal thinning linked to longer TOMM40 poly‐T variant lengths in the absence of the APOE ε4 variant
    Alison C. Burggren, Zanjbeel Mahmood, Theresa M. Harrison, Prabha Siddarth, Karen J. Miller, Gary W. Small, David A. Merrill, Susan Y. Bookheimer · 2017 · Alzheimer s & Dementia
60. Alzheimer’s disease: future drug development and the blood-brain barrier
    William M. Pardridge · 2019 · Expert Opinion on Investigational Drugs
61. Mouse Models of Neurodegenerative Diseases: Criteria and General Methodology
    Christopher Janus, Hans Welzl · 2009 · Methods in molecular biology
62. Processing Amyloid Precursor Protein at the β-Site Requires Proper Orientation to Be Accessed by BACE1
    Isam M. Qahwash, Wanxia He, Alfredo G. Tomasselli, Rolf F. Kletzien, Riqiang Yan · 2004 · Journal of Biological Chemistry
63. A multimodal, β-amyloid-targeted contrast agent
    Sashiprabha M. Vithanarachchi, Matthew J. Allen · 2012 · Chemical Communications
64. Canine Models of Inherited Musculoskeletal and Neurodegenerative Diseases
    Brett D. Story, Matthew E. Miller, Allison M. Bradbury, Emily D. Million, Dongsheng Duan, Toloo Taghian, Dominik Faissler, Deborah Fernau, Sidney J. Beecy, Heather L. Gray‐Edwards · 2020 · Frontiers in Veterinary Science
65. Effects of lysophosphatidylcholine on β-amyloid-induced neuronal apoptosis
    Zhenxia Qin, Hui-yan Zhu, Yinghe Hu · 2009 · Acta Pharmacologica Sinica
66. β-Amyloid enhances intracellular calcium rises mediated by repeated activation of intracellular calcium stores and nicotinic receptors in acutely dissociated rat basal forebrain neurons
    James H. Chin, Frederick W. Tse, Kim H. Harris, Jack H. Jhamandas · 2007 · Journal of Neurocytology
67. APP intracellular domain formation and unaltered signaling in the presence of familial Alzheimer’s disease mutations
    Anna Bergman, Dorota Religa, Helena Karlström, Hanna Laudon, Bengt G. Winblad, Lars Lannfelt, Johan Lundkvist, Jan Näslund · 2003 · Experimental Cell Research
68. Alzheimer’s Drug PBT2 Interacts with the Amyloid β 1–42 Peptide Differently than Other 8-Hydroxyquinoline Chelating Drugs
    Kelly L. Summers, Graham P. Roseman, Kevin M. Schilling, Natalia V. Dolgova, M. Jake Pushie, Dimosthenis Sokaras, Thomas Kröll, Hugh H. Harris, Glenn L. Millhauser, Ingrid J. Pickering et al. · 2022 · Inorganic Chemistry
69. The Flavonol Quercitrin Hinders GSK3 Activity and Potentiates the Wnt/β-Catenin Signaling Pathway
    Danilo Predes, Lorena Agostini Maia, Isadora C. Pereira Matias, Hannah P. Mota-Araujo, Carolina Soares, Fernanda G. Q. Barros‐Aragão, Luiz Fernando Silva Oliveira, Renata Rodrigues dos Reis, Nathália G. Amado, Alessandro B. C. Simas et al. · 2022 · International Journal of Molecular Sciences
70. β-amyloid oligomers and prion protein
    Gianluigi Forloni, Claudia Balducci · 2011 · Prion
71. The mechanism for heme to prevent Aβ1–40 aggregation and its cytotoxicity
    Qingui Bao, Ying Luo, Wěi Li, Xiaobo Sun, Cuiqing Zhu, Pingwei Li, Zhong‐Xian Huang, Xiangshi Tan · 2011 · JBIC Journal of Biological Inorganic Chemistry
72. Molecular Engineering of a Secreted, Highly Homogeneous, and Neurotoxic Aβ Dimer
    Andreas Müller‐Schiffmann, Aksana Andreyeva, Anselm H. C. Horn, Kurt Gottmann, Carsten Korth, Heinrich Sticht · 2011 · ACS Chemical Neuroscience
73. Detection of Alzheimer’s amyloid beta aggregation by capturing molecular trails of individual assemblies
    Mun’delanji Catherine M. Vestergaard, Tsutomu Hamada, Masato Saito, Yoshifumi Yajima, Monotori Kudou, Eiichi Tamiya, Masahiro Takagi · 2008 · Biochemical and Biophysical Research Communications
74. Imaging and In Vivo Quantitation of β-Amyloid: An Exemplary Biomarker for Alzheimer’s Disease?
    Lisa M. Nichols, Victor W. Pike, Lisheng Cai, Robert B. Innis · 2006 · Biological Psychiatry
75. Molecular determinants for amyloid fibril formation: lessons from lung surfactant protein C
    Jan Johansson · 2003 · Swiss Medical Weekly
76. Elevated ganglioside GM2 activator (GM2A) in human brain tissue reduces neurite integrity and spontaneous neuronal activity
    Yi‐Chen Hsieh, Joseph M. Negri, Amy He, Richard V. Pearse, Lei Liu, Duc Minh Duong, Lori Beth Chibnik, David Alan Bennett, Nicholas T. Seyfried, Tracy L. Young‐Pearse · 2022 · Molecular Neurodegeneration
77. Novel multipotent phenylthiazole–tacrine hybrids for the inhibition of cholinesterase activity, β-amyloid aggregation and Ca2+ overload
    Yue Wang, Fang Wang, Junping Yu, Fengchao Jiang, Xin‐Lei Guan, Can-Ming Wang, Lei Li, Hui Cao, Mingxing Li, Jianguo Chen · 2012 · Bioorganic & Medicinal Chemistry
78. Interleukin-1β interferes with signal transduction induced by neurotrophin-3 in cortical neurons
    Rungtip Soi‐ampornkul, Liqi Tong, Wipawan Thangnipon, R. Balázs, Carl W. Cotman · 2007 · Brain Research
79. Glycyrrhiza and Uncaria Hook contribute to protective effect of traditional Japanese medicine yokukansan against amyloid β oligomer-induced neuronal death
    Hitomi Kanno, Zenji Kawakami, Seiichi Iizuka, Masashi Tabuchi, Kazushige Mizoguchi, Yasushi Ikarashi, Yoshio Kase · 2013 · Journal of Ethnopharmacology
80. Essential involvement of the NMDA receptor in ethanol preconditioning‐dependent neuroprotection from amyloid‐βin vitro
    Robert M. Mitchell, Edward J. Neafsey, Michael A. Collins · 2009 · Journal of Neurochemistry
81. Preparation of pure populations of covalently stabilized amyloid β-protein oligomers of specific sizes
    Eric Y. Hayden, Joseph Conovaloff, Ashley J Mason, Gal Bitan, David B. Teplow · 2016 · Analytical Biochemistry
82. The Moringin/α-CD Pretreatment Induces Neuroprotection in an In Vitro Model of Alzheimer’s Disease: A Transcriptomic Study
    Serena Silvestro, Luigi Chiricosta, Agnese Gugliandolo, Renato Iori, Patrick Rollin, Daniele Perenzoni, Fulvio Mattivi, Placido Bramanti, Emanuela Mazzon · 2021 · Current Issues in Molecular Biology
83. Brain neprilysin activity and susceptibility to transgene-induced Alzheimer amyloidosis
    Troy L. Carter, Steve Pedrini, Jorge A. Ghiso, Michelle E. Ehrlich, Sam Gandy · 2005 · Neuroscience Letters
84. New approaches to diagnose and treat alzheimer's disease
    Douglas R Galasko · 2001 · Clinics in Geriatric Medicine
85. β-Amyloid therapies in Alzheimer’s disease
    Stanford S. Jhee, Thomas M. Shiovitz, Aaron W. Crawford, Neal R. Cutler · 2001 · Expert Opinion on Investigational Drugs
86. Intracerebroventricular passive immunization with anti‐oligoAβ antibody in TgCRND8
    Chauhan, Neelima B. · 2007 · Journal of Neuroscience Research
87. Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss
    Ronald K. Freund, Emily S. Gibson, Huntington Potter, Mark L. Dell’Acqua · 2016 · Molecular Pharmacology
88. Modeling the protonation states of β-secretase binding pocket by molecular dynamics simulations and docking studies
    Dima A. Sabbah, Haizhen A. Zhong · 2016 · Journal of Molecular Graphics and Modelling
89. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer’s disease mouse model
    Krystal Herline, Frances Prelli, Pankaj D Mehta, Claire MacMurray, Fernando Goñi, Thomas Wısnıewskı · 2018 · Alzheimer s Research & Therapy
90. Amyloid futures in the expanding pathology of brain aging and dementia
    Max Andrew Thorwald, Justine A. Silva, Elizabeth Head, Caleb E. Finch · 2022 · Alzheimer s & Dementia
91. Brain amyloid β protein and memory disruption in Alzheimer’s disease
    Weiming Xia · 2010 · Neuropsychiatric Disease and Treatment
92. The Effects of N-terminal Mutations on β-amyloid Peptide Aggregation and Toxicity
    Bahram V. Foroutanpay, J. Kumar, Sang‐Gyun Kang, N. Danaei, David A. Westaway, Valerie L. Sim, Satyabrata Kar · 2018 · Neuroscience
93. Inhibition of Early Upstream Events in Prodromal Alzheimer’s Disease by Use of Targeted Antioxidants
    Kedar Nath Prasad, Stephen Claude Bondy · 2014 · Current Aging Science
94. Long-Term High-Fat Diet Impairs AQP4-Mediated Glymphatic Clearance of Amyloid Beta
    Wei Peng, Ye Yuan, Jingna Lei, Yi Zhao, Yan Li, Qiumin Qu, Jin Wang · 2024 · Molecular Neurobiology
95. Implications of Gliotransmission for the Pharmacotherapy of CNS Disorders
    Daniela Rossi, Francesca Martorana, Liliana Brambilla · 2011 · CNS Drugs
96. The Design, Development, and Evaluation of BACE1 Inhibitors for the Treatment of Alzheimer’s Disease
    Arun Kumar Ghosh, Emilio L. Cárdenas, Heather L. Osswald · 2016 · Topics in medicinal chemistry
97. BACE-1 Inhibitors Targeting Alzheimer's Disease
    Kadja Luana Chagas Monteiro, Marcone Gomes dos Santos Alcântara, Nathalia Monteiro Lins Freire, Esaú Marques Brandão, Vanessa Lima do Nascimento, Líbni Maísa dos Santos Viana, Thiago Mendonça de Aquino, Edeildo Ferreira da Silva‐Júnior · 2023 · Current Alzheimer Research
98. Cholinergic Central System, Alzheimer's Disease, and Anesthetics Liaison: A Vicious Circle?
    Daniela Schifilliti, L. B. Santamaria, Giovanni Rosa, Gianfranco Di Nino, Pravat Kumar Mandal, Vincenzo Fodale · 2010 · Journal of Alzheimer s Disease
99. Glia: dos velhos conceitos às novas funções de hoje e as que ainda virão
    Flávia Carvalho Alcântara Gomes, Vanessa Tortelli, Luan Pereira Diniz · 2013 · Estudos Avançados
100. l -Dopa and dopamine conjugated naphthalenediimides modulate amyloid β toxicity
     Madhu Ramesh, Pandeeswar Makam, Chandrashekhar Voshavar, Harshavardhan Khare, Kolla Rajasekhar, Suryanarayanarao Ramakumar, Thimmaiah Govindaraju · 2018 · Organic & Biomolecular Chemistry